Eat less, live longer: what do we actually know about dietary restriction?
Caloric restriction, fasting, protein restriction -- dietary interventions have captured the attention of aging researchers for decades. But what genuinely works, and what is just marketing noise? A new review article in Nature Aging lays it all out: the evidence, the conflicting data, the side effects, and the promising drugs that mimic the same effects. The answer is more nuanced than you might hope, but also surprisingly encouraging.
From worms to humans: what does the research actually show?
In laboratory studies, the effect of dietary restriction on lifespan is striking. In yeast, worms, flies, and mice, it consistently extends lifespan, sometimes dramatically. In primates -- species biologically close to us -- the results are more mixed, but clear benefits for metabolic health, inflammatory markers, and age-related disease are still visible. In humans, direct evidence for lifespan extension is hard to gather, simply because people live so long. Yet studies such as CALERIE, a controlled trial of 25% caloric restriction in healthy adults, show that even moderate restriction improves biological aging markers, lowers blood pressure, and reduces inflammation.
The authors also examine the different forms of dietary restriction. Total caloric restriction is one approach, but there is also protein restriction, restriction of specific amino acids such as methionine, and various forms of intermittent fasting. Each mechanism engages different biological pathways. Caloric restriction activates AMPK (essentially an energy sensor inside your cells) and suppresses mTOR (a growth-promoting signaling pathway that, when overactive, accelerates aging). Fasting triggers autophagy -- your cells' own housekeeping process, in which damaged material is broken down and recycled.
Pills that do what dieting does
One of the most intriguing sections of the article concerns pharmacological mimics of dietary restriction. Drugs such as metformin (well known from diabetes treatment), rapamycin (an immunosuppressant), and resveratrol activate biological pathways similar to those triggered by fasting or caloric restriction -- without you having to go hungry. Metformin is already being investigated in the large TAME trial as a potential anti-aging drug. The authors are cautious but not pessimistic: they flag side effects and note that dietary restriction itself is not without risks, including muscle loss in older adults.
For you as a general reader, the take-home message is clear: you do not need to become an extreme dieter to benefit from the mechanisms behind dietary restriction. Eating in moderation, building regular shorter fasting periods into your routine, and paying attention to protein quality in your diet are all accessible steps. Science is steadily handing you more tools -- both practical ones and, in the future, pharmacological ones -- to slow your biological aging.